PCI 2013

为提高中国心脏介入手术治疗水平，提倡分享与交流的学术氛围，同时促进临床药物规范化应用，中国医师协会心血管内科医师分会和《中国介入心脏病学杂志》社有限公司于2013年隆重推出PCI精彩病例分享活动。

这是中国权威的心血管组织和核心学术期刊与全球品牌制药企业阿斯利康公司协作，共同在心血管领域内开展的大型学术活动。

In order to improve China cardiac intervention treatment level, to promote the sharing and exchange of academic atmosphere, while promoting the standardization of application of clinical drug Cardiovascular Medicine Doctor Association Chinese Medical Association and Chinese Journal of Interventional Cardiology "social Limited 2013 grand launch of PCI wonderful case-sharing activities.

This is a large academic authority cardiovascular tissue and core academic journals and the global brand pharmaceutical companies AstraZeneca collaborate within the cardiovascular field activities.